Cartography Biosciences, Inc.

As the son of two scientists, Kevin Parker, 31, never wanted to be a scientist. “I did not grow up thinking that I wanted to be a scientist,” he said. “Both of my parents are PhDs in organic chemistry

Included for 2025 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, and individuals spearheading unique health initiatives worldwide. The 30 individuals list

Pharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur